12.07.2013 Views

Safety evaluation of certain food additives - ipcs inchem

Safety evaluation of certain food additives - ipcs inchem

Safety evaluation of certain food additives - ipcs inchem

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ETHYL LAUROYL ARGINATE 67<br />

Body weight gain <strong>of</strong> animals receiving 1000 mg/kg bw per day was<br />

significantly lower than that <strong>of</strong> the controls throughout treatment (45% <strong>of</strong> that <strong>of</strong><br />

controls). Food consumption in this treatment group was significantly lower in the<br />

2nd week <strong>of</strong> treatment (days 13–19 <strong>of</strong> gestation, 79% <strong>of</strong> that <strong>of</strong> controls). These<br />

effects were considered by the authors to be treatment related. Body weight gains<br />

and <strong>food</strong> consumption <strong>of</strong> animals receiving 100 and 300 mg/kg bw per day were<br />

similar to those <strong>of</strong> controls. There were no treatment-related effects upon the dam<br />

or litter survival or on fetal or placental weight. There was a low incidence <strong>of</strong> fetal<br />

anomalies in all groups, which were not related to treatment. The authors concluded<br />

that 300 mg ethyl lauroyl arginate/kg bw per day (equal to 207 mg ethyl-N -lauroyl-<br />

L-arginate HCl/kg bw per day) was the NOAEL for the dam, based on effects on<br />

maternal body weight gain and <strong>food</strong> intake. The NOAEL for the fetus was concluded<br />

to be 1000 mg ethyl lauroyl arginate/kg bw per day (equal to 691 mg ethyl-N -lauroyl-<br />

L-arginate HCl/kg bw per day), based on no adverse effects upon survival and<br />

development up to the maximum dose tested (Huntingdon Life Sciences Ltd, 1998f).<br />

2.3 Observations in humans<br />

Three adverse events were reported by two <strong>of</strong> six subjects in a<br />

pharmacokinetic study reported in section 2.1.1. One subject at 2.5 mg/kg bw<br />

reported headache, and one subject at 1.5 mg/kg bw reported diarrhoea and<br />

flatulence. Both events were considered to be mild in nature, and the authors<br />

concluded that these events were unlikely to be related to treatment. There were<br />

no clinically significant changes in the clinical parameters assessed (CentraLabS<br />

Clinical Research Ltd, 2005b).<br />

3. DIETARY EXPOSURE<br />

3.1 Introduction<br />

The Committee has not previously evaluated the dietary exposure to ethyl<br />

lauroyl arginate. Ethyl lauroyl arginate is used as a preservative to protect <strong>food</strong><br />

against microbial contamination and spoilage. The active ingredient responsible for<br />

the preservative action is ethyl-N-lauroyl-L-arginate HCl, which is present in the<br />

article <strong>of</strong> commerce at a level in the range 85–95%. The Committee noted that use<br />

levels based on the active ingredient are approximately 15% lower than those based<br />

on the article <strong>of</strong> commerce (i.e. the use level for the article <strong>of</strong> commerce is “up to<br />

225 mg/kg” compared with “up to 200 mg/kg” for the active ingredient).<br />

3.2 Use in <strong>food</strong>s<br />

Ethyl lauroyl arginate is used in the <strong>food</strong> categories listed in Table 6, at the<br />

levels indicated therein.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!